Search filters

List of works by Nicoletta Colombo

#523 Initial efficacy and safety results from ENGOT-Ov60/GOG-3052/RAMP 201: a phase 2 study of avutometinib (VS-6766) ± defactinib in recurrent low-grade serous ovarian cancer (LGSOC)

A Blastic Plasmacytoid Dendritic Cell Neoplasm-like Phenotype Identifies a Subgroup of NPM1-Mutated AML Patients with Worse Prognosis While Has Not Predictive Value in NPM1-Wt AML ⬇️

scholarly article

A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups

scientific article published on 10 October 2019

A Novel Synthetic Lethal Approach Targeting SIRT6 in Acute Myeloid Leukemia ⬇️

scholarly article

A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib.

scientific article published on 5 May 2010

A blastic plasmacytoid dendritic cell neoplasm-like phenotype identifies a subgroup of npm1-mutated acute myeloid leukemia patients with worse prognosis.

scientific article

A cell-of-origin epigenetic tracer reveals clinically distinct subtypes of high-grade serous ovarian cancer

scientific article published on 30 October 2020

A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer.

scientific article

A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma.

scientific article published on 30 July 2018

A phase II study of aflibercept in patients with advanced epithelial ovarian cancer and symptomatic malignant ascites

scientific article published on 21 November 2011

A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal, or peritoneal cancer and platinum tre

scientific article published on 14 December 2020

A randomized phase II trial of maintenance therapy with Sorafenib in front-line ovarian carcinoma.

scientific article published on 13 April 2013

A simple cytofluorimetric score may optimize testing for biallelic CEBPA mutations in patients with acute myeloid leukemia

scientific article published on 06 September 2019

Abagovomab as maintenance therapy in patients with epithelial ovarian cancer: a phase III trial of the AGO OVAR, COGI, GINECO, and GEICO--the MIMOSA study

scientific article published on 11 March 2013

Adjuvant chemotherapy in stage I-II uterine leiomyosarcoma: a multicentric retrospective study of 140 patients

scientific article published on 11 March 2014

Adult granulosa cell tumours of the ovary

scientific article published on September 2014

Adult primary cervical rhabdomyosarcomas: A Multicentric cross-national case series

scientific article published on 27 November 2019

Advanced low grade serous ovarian cancer: A retrospective analysis of surgical and chemotherapeutic management in two high volume oncological centers

scientific article published on 27 September 2022

Allogeneic Transplanst for ACUTE Myeloid Leukemia: Cut Off Levels of WT1 Expression in 207 Patients and Pre-Emptive Therapy of Relapse ⬇️

scholarly article

An open-label phase 2 study of twice-weekly bortezomib and intermittent pegylated liposomal doxorubicin in patients with ovarian cancer failing platinum-containing regimens.

scientific article

Anthracycline-based and gemcitabine-based chemotherapy in the adjuvant setting for stage I uterine leiomyosarcoma: a retrospective analysis at two reference centers

scientific article published on 28 August 2020

Are monoclonal antibodies a safe treatment for cancer during pregnancy?

scientific article published on July 2013

Aromatase Inhibitors as Adjuvant Treatment for ER/PgR Positive Stage I Endometrial Carcinoma: A Retrospective Cohort Study

scientific article published on 23 March 2020

Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study

scientific article published on 09 July 2019

BRCA1/2 Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories

scientific article published on 09 October 2019

BRCA1/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR 16 study.

scientific article

Bevacizumab in ovarian cancer: Focus on clinical data and future perspectives.

scientific article

Building clinical trials around patients: Evaluation and comparison of decentralized and conventional site models in patients with low back pain

scientific article published on 28 June 2018

CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells.

scientific article published on 10 March 2018

CT-Based Radiomics and Deep Learning for BRCA Mutation and Progression-Free Survival Prediction in Ovarian Cancer Using a Multicentric Dataset

scientific article published on 31 May 2022

Catumaxomab with and without prednisolone premedication for the treatment of malignant ascites due to epithelial cancer: results of the randomised phase IIIb CASIMAS study

scientific article published on 26 June 2014

Cell division cycle 7 kinase inhibitors: 1H-pyrrolo[2,3-b]pyridines, synthesis and structure-activity relationships

scientific article

Chemo-conization in early cervical cancer

scientific article published on 29 August 2007

Clinical benefit and risk of death with endocrine therapy in ovarian cancer: A comprehensive review and meta-analysis

scientific article

Clinical presentation, diagnosis and management of Therapy-Related Hematological Disorders in Women with Epithelial Ovarian Cancer treated with Chemotherapy and Poly-ADP-Ribose Polymerase Inhibitors (PARP-i): a single Center experience

scientific article published on 28 August 2020

Combined Assessment of WT1 and BAALC Expression Levels Improves Risk Stratification in Myelodysplastic Syndromes ⬇️

scholarly article

Combined assessment of WT1 and BAALC gene expression at diagnosis may improve leukemia-free survival prediction in patients with myelodysplastic syndromes

scientific article published on 27 April 2015

Combining Flow Cytometry and Molecular Assessment Improves the Prognostic Value of Pre-Transplant Minimal Residual Disease in Acute Myeloid Leukemia ⬇️

scholarly article

Combining flow cytometry and WT1 assessment improves the prognostic value of pre-transplant minimal residual disease in acute myeloid leukemia.

scientific article published on 11 May 2017

Concordance between CA-125 and RECIST progression in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer treated in the SOLO2 trial with olaparib as maintenance therapy after response to chemotherapy

scientific article published on 22 September 2020

Concordance between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial

scientific article published on 29 December 2020

Corrigendum to "Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia)" [Eur J Canc. vol. 139 November (2020) Pages 149-168]

scientific article published on 19 December 2020

Critical Review of Neoadjuvant Chemotherapy Followed by Surgery for Locally Advanced Cervical Cancer ⬇️

scientific article published on October 1, 2010

Current academic clinical trials in ovarian cancer: Gynecologic Cancer Intergroup and US National Cancer Institute Clinical Trials Planning Meeting, May 2009

scientific article

Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients

scientific article published on 4 November 2016

DNA methylation signatures to predict the cervicovaginal microbiome status

scientific article published on 23 November 2020

Data from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Data from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Data from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened "GO question".

scientific article published on 18 May 2013

Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells' vulnerability to DNA-damaging agents.

scientific article published on 12 October 2017

Detection of an Unbalanced Ratio Between WT1 Isoforms in Acute Myeloid Leukemia and Its Correlation with Molecular Abnormalities. ⬇️

scholarly article

Diaphragmatic surgery during primary cytoreduction for advanced ovarian cancer: peritoneal stripping versus diaphragmatic resection.

scientific article published in December 2011

Discovery of NMS-E973 as novel, selective and potent inhibitor of heat shock protein 90 (Hsp90)

scientific article

Double-Blind, Placebo-Controlled, Randomized Phase III Trial Evaluating Pertuzumab Combined With Chemotherapy for Low Tumor Human Epidermal Growth Factor Receptor 3 mRNA-Expressing Platinum-Resistant Ovarian Cancer (PENELOPE).

scientific article

ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer

scientific article

ENGOT-ov60/GOG-3052/RAMP 201: A phase 2 study of VS-6766 (RAF/MEK clamp) alone and in combination with defactinib (FAK inhibitor) in recurrent low-grade serous ovarian cancer (LGSOC).

scientific article published in June 2022

ESGO Statement on the Role of CA‐125 Measurement in Follow-Up of Epithelial Ovarian Cancer

scientific article published in January 2012

ESGO statement on cervical cancer vaccination

scientific article published on 01 November 2007

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

scientific article published on 18 December 2020

ESMO management and treatment adapted recommendations in the COVID-19 era: gynaecological malignancies

scientific article published on 01 July 2020

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up

scientific article

ESMO–ESGO–ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up

scientific article published on 09 December 2015

Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information

scientific article

Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers

scientific article published on 16 October 2020

Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study

scientific article published on 04 October 2016

Efficacy and safety of alpelisib plus olaparib versus chemotherapy among patients with platinum-resistant or refractory high-grade serous ovarian cancer without BRCA mutation: Primary analysis of the EPIK-O trial

scientific article published in November 2024

Efficacy of Maintenance Olaparib for Patients With Newly Diagnosed Advanced Ovarian Cancer With a BRCA Mutation: Subgroup Analysis Findings From the SOLO1 Trial

scientific article published on 04 August 2020

Efficacy of Trabectedin in Platinum-Sensitive-Relapsed Ovarian Cancer: New Data From the Randomized OVA-301 Study ⬇️

scientific article published on May 1, 2011

Emerging treatment strategies in recurrent platinum-sensitive ovarian cancer: focus on trabectedin

scientific article published on 08 August 2013

Epigenome-based cancer risk prediction: rationale, opportunities and challenges

scientific article published on 27 February 2018

European Network of Gynaecological Oncological Trial Groups’ Requirements for Trials Between Academic Groups and Industry Partners—First Update 2015

scientific article published in September 2015

Evaluating treatment response of chronic myeloid leukemia: emerging science and technology.

scientific article published on September 2013

Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer

scientific article published on 20 March 2018

Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup

scientific article

Experience with trabectedin + pegylated liposomal doxorubicin for recurrent platinum-sensitive ovarian cancer unsuited to platinum rechallenge

scientific article published on November 2016

External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma ⬇️

scientific article published on May 15, 2013

FORWARD I: a Phase III study of mirvetuximab soravtansine versus chemotherapy in platinum-resistant ovarian cancer

scientific article published on 9 February 2018

Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial.

scientific article published on 16 December 2016

Feasibility of Transabdominal Cardiophrenic Lymphnode Dissection in Advanced Ovarian Cancer: Initial Experience at a Tertiary Center.

scientific article published on 12 May 2017

Fertility-Sparing Options in Young Women with Cervical Cancer.

scientific article

Fibroblastic Malignant Peripheral Nerve Sheath Tumour of the Uterine Cervix: Report of a Case and Literature Review With Emphasis on Possible Differential Diagnosis

scientific article published on 22 February 2018

Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer

scientific article published on 06 September 2019

Finding the Best Therapy for Elderly Frail AML Patients: A Retrospective Comparison of 5-Azacytidine and Intensive Approach ⬇️

scholarly article

First-Line Treatment  with Olaparib for Early Stage BRCA-Positive Ovarian Cancer: May It Be Possible? Hypothesis Potentially Generating a Line of Research

scientific article published on 07 July 2020

First-line therapy in ovarian cancer trials.

scientific article published on May 2011

Fludarabine, High-Dose Cytarabine and Idarubicin-Based Induction May Overcome the Negative Prognostic Impact of <i>FLT3</i>-ITD in <i>NPM1</i> Mutated AML, Irrespectively of <i>FLT3</i>-ITD Allelic Burden

scientific article published on 24 December 2020

Fludarabine, cytarabine and Idarubicin (FLAI-5) with or without Gemtuzumab Ozogamicin Is an Effective and Well Tolerated Regimen for Younger AML Patients: Real Life Data from a Single Center Register ⬇️

scholarly article

Follow-up in Gynecological Malignancies: A State of Art.

scientific article published on 24 July 2015

Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitors

scientific article

Giovanni Bartolena. Un novecentista sulle orme della Macchia

Art book, first in the series 'The masters of light in Tuscany'

Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian sex cord stromal tumors

scientific article

High Predictive Value of Pre Transplant Minimal Residual Disease Assessment By Combining WT1 Expression and Flow Cytometry in Acute Myeloid Leukemia ⬇️

scholarly article

High Prognostic Value of a 3-Genes Molecular Score in Non-High Risk Acute Promyelocytic Leukemia Treated with AIDA 2000 Protocol: A Retrospective Study from a Regional Register ⬇️

scholarly article

High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients

scientific article published on 16 April 2016

High precision radiotherapy including intensity-modulated radiation therapy and pulsed-dose-rate brachytherapy for cervical cancer: a retrospective monoinstitutional study

scientific article published on 08 December 2019

How to Address Sexual Problems in Female Cancer Patients

scientific article published on April 2017

Identification of potent pyrazolo[4,3-h]quinazoline-3-carboxamides as multi-cyclin-dependent kinase inhibitors

scientific article

Impact of Recurrence of Ovarian Cancer on Quality of Life and Outlook for the Future

scientific article

Implementing clinical practice guidelines: time to assess it

scientific article published on 01 November 2020

Incorporation of pazopanib in maintenance therapy of ovarian cancer

scientific article

Integrating post induction WT1 quantification and flow-cytometry results improves minimal residual disease stratification in acute myeloid leukemia ⬇️

scientific article published on July 23, 2013

Intensity modulated radiation therapy boost in locally-advanced cervical cancer in the absence of brachytherapy

scientific article published on 17 March 2020

International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma

scientific article

International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer

scientific article published on 01 January 2003

Intravenous aflibercept in patients with platinum-resistant, advanced ovarian cancer: results of a randomized, double-blind, phase 2, parallel-arm study.

scientific article published on 11 October 2013

Is Endometrial Cancer Risk Reduced by Oral Bisphosphonate Use?

scientific article published on 17 August 2015

Leukaemia relapse after allogeneic transplants for acute myeloid leukaemia: predictive role of WT1 expression

scientific article published on 07 January 2013

Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients

scientific article published on 03 July 2015

Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancer

scientific article published on 18 August 2016

Longitudinal minimal residual disease (MRD) evaluation in acute myeloid leukaemia with NPM1 mutation: from definition of molecular relapse to MRD-driven salvage approach

scientific article published on 26 July 2019

MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum

scientific article published on 21 August 2020

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

article

Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial

scientific article published in 2021

Management of ovarian stromal cell tumors

scientific article published on July 2007

Mechanisms and Clinical Applications of Genome Instability in Multiple Myeloma.

scientific article published on 22 October 2015

Medical treatment of early stage and rare histological variants of epithelial ovarian cancer

scientific article

Minimal Residual Disease After the First Cycle of Chemotherapy in Acute Myeloid Leukemia: A Comparative Study of WT1 RQ-PCR and 4-Color Flow Cytometry. ⬇️

scholarly article

Minimal Residual Disease Assessment May Drive Post Remission Therapy in Acute Myeloid Leukemia. It's Time for MRD-Driven Therapy ⬇️

scholarly article

Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

scientific article published on 15 August 2023

Molecular analysis of the Imatinib-induced complete cytogenetic response in chronic myelogenous leukemia

scientific article published in July 2006

Molecular recognition of T:G mismatched base pairs in DNA as studied by electrospray ionization mass spectrometry

scientific article

Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities

scientific article published on 23 October 2013

Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer

scientific article published on 20 September 2019

Multidisciplinary approach in the management of advanced ovarian cancer patients: A personalized approach. Results from a specialized ovarian cancer unit.

scientific article published on 20 January 2017

Neoadjuvant chemotherapy in cervical cancer: an update

scientific article published on 07 September 2015

Next-generation sequencing-based BRCA testing on cytological specimens from ovarian cancer ascites reveals high concordance with tumour tissue analysis

scientific article published on 19 September 2019

Novel pyrrole carboxamide inhibitors of JAK2 as potential treatment of myeloproliferative disorders

scientific article

Nucleophosmin gene-based monitoring in de novo cytogenetically normal acute myeloid leukemia with nucleophosmin gene mutations: comparison with cytofluorimetric analysis and study of Wilms tumor gene 1 expression.

scientific article published on 21 May 2012

Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial

scientific article published on 19 February 2020

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial.

scientific article published on 4 December 2014

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer

scientific article published on 01 December 2019

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

scientific article

Optimising the treatment of the partially platinum-sensitive relapsed ovarian cancer patient

scientific article

Optimization of diarylthiazole B-raf inhibitors: identification of a compound endowed with high oral antitumor activity, mitigated hERG inhibition, and low paradoxical effect

scientific article

Optimizing treatment of the partially platinum-sensitive ovarian cancer patient

scientific article published on December 2013

Outcome according to residual disease (surgeon's report vs pre-chemotherapy imaging) in patients with bevacizumab-treated ovarian cancer: Analysis of the ROSiA study

scientific article published on 31 July 2019

Ovarian cancer

scientific article published on 02 October 2006

Overall survival data from a 3-arm, randomized, open-label, phase 2 study of relacorilant, a selective glucocorticoid receptor modulator, combined with nab-paclitaxel in patients with recurrent platinum-resistant ovarian cancer.

scientific article published in 2022

PO004LBA/#1515 Efficacy and safety of avutometinib + defactinib in recurrent low-grade serous ovarian cancer following prior systemic therapy

Parp inhibitors as maintenance treatment in platinum sensitive recurrent ovarian cancer: An updated meta-analysis of randomized clinical trials according to BRCA mutational status

scientific article published on 09 October 2019

Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma

scientific article published on 24 August 2020

Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer

scientific article published on 15 August 2019

Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan

scientific article published on 2 May 2009

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer ⬇️

journal article from 'New England Journal of Medicine' published in 2021

Pertuzumab Plus Chemotherapy for Platinum-Resistant Ovarian Cancer: Safety Run-in Results of the PENELOPE Trial

scientific article

Phase 2 study evaluating intermittent and continuous linsitinib and weekly paclitaxel in patients with recurrent platinum resistant ovarian epithelial cancer

scientific article published on 14 February 2018

Platinum, anthracycline, and alkylating agent-based chemotherapy for ovarian carcinosarcoma

scientific article published in August 2009

Platinum-based neoadjuvant chemotherapy followed by radical surgery for cervical carcinoma international federation of gynecology and obstetrics stage IB2-IIB.

scientific article published in November 2013

Pre-chemotherapy hemoglobin levels and survival in patients with advanced epithelial ovarian cancer who received a first-line taxane/platinum-based regimen: results of a multicenter retrospective Italian study

scientific article published in July 2005

Pre-operative evaluation of epithelial ovarian cancer patients: Role of whole body diffusion weighted imaging MR and CT scans in the selection of patients suitable for primary debulking surgery. A single-centre study

scientific article published on 13 December 2019

Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer

scientific article published on 04 August 2020

Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer ⬇️

scientific article published on August 1, 2010

Prognostic Value of Minimal Residual Disease Assessed By WT1 Expression Level and Flow Cytometry in Acute Myeloid Leukemia Patients Undergoing Allogeneic Marrow Transplantation ⬇️

scholarly article

Prognostic relevance of a blastic plasmacytoid dendritic cell neoplasm-like immunophenotype in cytogenetically normal acute myeloid leukemia patients

scientific article published on 18 March 2020

Progression-free survival by local investigator versus independent central review: comparative analysis of the AGO-OVAR16 Trial

scientific article

Radiation exposure of ovarian cancer patients: contribution of CT examinations performed on different MDCT (16 and 64 slices) scanners and image quality evaluation: an observational study

scientific article

Radioimmunotherapy in advanced ovarian cancer: is there a role for pre-targeting with (90)Y-biotin?

scientific article

Radiomics of high-grade serous ovarian cancer: association between quantitative CT features, residual tumour and disease progression within 12 months

scientific article published on 08 May 2018

Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: a European Organisation for Research and Treatment of Cancer-Gynaecologi

scientific article

Randomized phase III trial on trabectedin (ET-743) single agent versus clinician’s choice chemotherapy in recurrent ovarian, primary peritoneal, or fallopian tube cancers of BRCA-mutated or BRCAness phenotype patients (MITO23).

scientific article published in 2022

Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvan

scientific article

Randomized, Open-Label, Phase III Study Comparing Patupilone (EPO906) With Pegylated Liposomal Doxorubicin in Platinum-Refractory or -Resistant Patients With Recurrent Epithelial Ovarian, Primary Fallopian Tube, or Primary Peritoneal Cancer

Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives

scientific article published on 25 May 2019

Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients

scientific article

Recommendations of the Fertility Task Force of the European Society of Gynecologic Oncology about the conservative management of ovarian malignant tumors.

scientific article published on July 2011

Recurrent ovarian cancer 8 months after induction and bevacizumab consolidation: rationale for using trabectedin + pegylated liposomal doxorubicin in second line

scientific article published on 01 October 2018

Reduction of postoperative complication rate with the use of early oral feeding in gynecologic oncologic patients undergoing a major surgery: a randomized controlled trial

scientific article published in November 2009

Relacorilant + Nab-Paclitaxel in Patients With Recurrent, Platinum-Resistant Ovarian Cancer: A Three-Arm, Randomized, Controlled, Open-Label Phase II Study

scientific article published on 20 October 2023

Reply to M.L. Friedlander et al ⬇️

scientific article published on June 20, 2013

Restoring platinum sensitivity in recurrent ovarian cancer by extending the platinum-free interval: Myth or reality?

scientific article

Results of the interprofessional and interdisciplinary Berlin round table on patient-reported outcomes, quality of life, and treatment expectations of patients with gynecological cancer under maintenance treatment

scientific article published on 16 August 2020

Risk-reducing Salpingo-Oophorectomy in Women at Higher Risk of Ovarian and Breast Cancer: A Single Institution Prospective Series

scientific article published in September 2017

Robotic Versus Open Radical Hysterectomy in Women With Locally Advanced Cervical Cancer After Neoadjuvant Chemotherapy: A Single-institution Experience of Surgical and Oncologic Outcomes

scientific article published on 5 May 2016

Robotic approach for cervical cancer: comparison with laparotomy: a case control study.

scientific article

Robotic surgery: changing the surgical approach for endometrial cancer in a referral cancer center

scientific article published on 21 May 2009

Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: Surgical and oncological outcomes. Single institution experience

scientific article published on 25 August 2010

Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial

scientific article published on 01 May 2020

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

scientific article published on 12 September 2017

SIRT6 Inhibition As a Novel Approach for Treating Acute Myeloid Leukemia ⬇️

scholarly article

Safety and Efficacy of Extended Bevacizumab Therapy in Elderly (≥70 Years) Versus Younger Patients Treated for Newly Diagnosed Ovarian Cancer in the International ROSiA Study

scientific article published on 01 May 2018

Secondary de-bulking surgery in recurrent ovarian cancer

scholarly article

Seventeen years of experience with ATRA-based therapy for acute promyelocytic leukaemia: long-term follow-up of patients treated at S. Martino Hospital, Genoa

scientific article published in April 2009

Special issues in fertility preservation for gynecologic malignancies

scientific article published on 07 September 2015

Splenectomy as part of primary cytoreductive surgery for advanced ovarian cancer: a retrospective cohort study.

scientific article published in July 2012

Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial

scientific article

Stereotactic Body Radiation Therapy for Oligometastatic Ovarian Cancer: A Step Toward a Drug Holiday

scientific article published on 04 April 2018

Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Synchronous and Metachronous Breast and Ovarian Cancer: Experience From Two Large Cancer Center

scientific article published on 14 December 2020

The European Network for Gynaecological Oncological Trial Groups Charta for Privileged Partnership

scientific article published in July 2015

The European society of gynaecological oncology: update on objectives and educational and research activities

scientific article published on January 2012

The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale

article

The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signalling

scientific article

The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium

scientific article published on February 2008

The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma

scientific article published on 31 July 2020

The role of restaging borderline ovarian tumors: single institution experience and review of the literature.

scientific article published on 24 August 2010

The work place educational climate in gynecological oncology fellowships across Europe: the impact of accreditation

scientific article published on January 2015

Trabectedin as single agent in relapsed advanced ovarian cancer: results from a retrospective pooled analysis of three phase II trials ⬇️

scientific article published on 09 February 2013

Trabectedin for women with ovarian carcinoma after treatment with platinum and taxanes fails.

scientific article

Training in Bowel and Upper Abdominal Surgery in Gynaecological Oncology

scientific article published in June 2011

Treatment of Minimal Residual Disease (MRD) with Donor Lymphocyte Infusions (DLI) in Acute Leukemia Patients Undergoing an Allogeneic Hemopoietic Stem Cell Transplants (HSCT). ⬇️

scholarly article

Treatment of recurrent ovarian cancer relapsing 6-12 months post platinum-based chemotherapy

scientific article published on 12 June 2007

Treatment options for pregnant women with ovarian tumors

scientific article published on July 2014

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

scientific article published on 07 May 2019

Tumor BRCA Test for Patients with Epithelial Ovarian Cancer: The Role of Molecular Pathology in the Era of PARP Inhibitor Therapy

scientific article published on 24 October 2019

Tumor progression and metastatic dissemination in ovarian cancer after dose-dense or conventional paclitaxel and cisplatin plus bevacizumab

scientific article published on 07 August 2018

Ultrasonographic diagnosis and longitudinal follow-up of recurrences after conservative surgery for borderline ovarian tumors.

scientific article published on 18 July 2016

Using the expected survival to explain differences between the results of randomized trials: a case in advanced ovarian cancer

scientific article published in May 2003

Value of Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer: A European Perspective.

scientific article published on 9 January 2017

WT1 overexpression at diagnosis may predict favorable outcome in patients withde novonon-M3 acute myeloid leukemia ⬇️

scientific article published on October 1, 2011

When nonplatinum is the answer: the role of trabectedin plus pegylated liposomal doxorubicin in recurrent ovarian cancer

scientific article published on 11 October 2017

Wilms Tumor 1 Expression and Pre-emptive Immunotherapy in Patients with Acute Myeloid Leukemia Undergoing an Allogeneic Hemopoietic Stem Cell Transplantation

scientific article published on 10 March 2016

Paulina is supported by:

About Paulina

Help